These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 26105028)

  • 1. Impact of a New Fusion Receptor on PD-1-Mediated Immunosuppression in Adoptive T Cell Therapy.
    Kobold S; Grassmann S; Chaloupka M; Lampert C; Wenk S; Kraus F; Rapp M; Düwell P; Zeng Y; Schmollinger JC; Schnurr M; Endres S; Rothenfußer S
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26105028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma.
    Rataj F; Kraus FBT; Chaloupka M; Grassmann S; Heise C; Cadilha BL; Duewell P; Endres S; Kobold S
    Front Immunol; 2018; 9():1955. PubMed ID: 30214445
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor PD-L1 co-stimulates primary human CD8(+) cytotoxic T cells modified to express a PD1:CD28 chimeric receptor.
    Prosser ME; Brown CE; Shami AF; Forman SJ; Jensen MC
    Mol Immunol; 2012 Jul; 51(3-4):263-72. PubMed ID: 22503210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model.
    Morales-Kastresana A; Sanmamed MF; Rodriguez I; Palazon A; Martinez-Forero I; Labiano S; Hervas-Stubbs S; Sangro B; Ochoa C; Rouzaut A; Azpilikueta A; Bolaños E; Jure-Kunkel M; Gütgemann I; Melero I
    Clin Cancer Res; 2013 Nov; 19(22):6151-62. PubMed ID: 24030703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer.
    Guo Z; Wang H; Meng F; Li J; Zhang S
    J Transl Med; 2015 Jul; 13():247. PubMed ID: 26219551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fate and function of anti-CD3/CD28-activated T cells following adoptive transfer: IL-2 promotes development of anti-tumor memory T cells in vivo.
    Hughes DP; Baskar D; Urban FF; Friedman MS; Braun TM; McDonagh KT
    Cytotherapy; 2005; 7(5):396-407. PubMed ID: 16236629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined CD4+ Th1 effect and lymphotactin transgene expression enhance CD8+ Tc1 tumor localization and therapy.
    Huang H; Bi XG; Yuan JY; Xu SL; Guo XL; Xiang J
    Gene Ther; 2005 Jun; 12(12):999-1010. PubMed ID: 15789061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication.
    Wang XF; Lei Y; Chen M; Chen CB; Ren H; Shi TD
    J Viral Hepat; 2013 Apr; 20 Suppl 1():27-39. PubMed ID: 23458522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced tumor-antigen density leads to PD-1/PD-L1-mediated impairment of partially exhausted CD8⁺ T cells.
    Kaiser AD; Schuster K; Gadiot J; Borkner L; Daebritz H; Schmitt C; Andreesen R; Blank C
    Eur J Immunol; 2012 Mar; 42(3):662-71. PubMed ID: 22144176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses.
    Wahl C; Bochtler P; Chen L; Schirmbeck R; Reimann J
    Gastroenterology; 2008 Sep; 135(3):980-8. PubMed ID: 18621049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of lymphotactin and interferon gamma-inducible protein-10 transgene expression in T-cell localization and adoptive T-cell therapy of tumors.
    Huang H; Xiang J
    Int J Cancer; 2004 May; 109(6):817-25. PubMed ID: 15027114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression.
    Shindo Y; Unsinger J; Burnham CA; Green JM; Hotchkiss RS
    Shock; 2015 Apr; 43(4):334-43. PubMed ID: 25565644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system.
    Na SY; Cao Y; Toben C; Nitschke L; Stadelmann C; Gold R; Schimpl A; Hünig T
    Brain; 2008 Sep; 131(Pt 9):2353-65. PubMed ID: 18669487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel model of antigen-specific induction of bile duct injury.
    Buxbaum J; Qian P; Khuu C; Shneider BL; Daikh DI; Gershwin ME; Allen PM; Peters MG
    Gastroenterology; 2006 Dec; 131(6):1899-906. PubMed ID: 17087941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cells.
    John LB; Devaud C; Duong CP; Yong CS; Beavis PA; Haynes NM; Chow MT; Smyth MJ; Kershaw MH; Darcy PK
    Clin Cancer Res; 2013 Oct; 19(20):5636-46. PubMed ID: 23873688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-γ-induced PD-L1 surface expression on human oral squamous carcinoma via PKD2 signal pathway.
    Chen J; Feng Y; Lu L; Wang H; Dai L; Li Y; Zhang P
    Immunobiology; 2012 Apr; 217(4):385-93. PubMed ID: 22204817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CD8 T cell response to vaccinia virus exhibits site-dependent heterogeneity of functional responses.
    Xiao Z; Curtsinger JM; Prlic M; Jameson SC; Mescher MF
    Int Immunol; 2007 Jun; 19(6):733-43. PubMed ID: 17545279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-1/PD-L1 expression on CD(4+) T cells and myeloid DCs correlates with the immune pathogenesis of atrial fibrillation.
    Liu L; Zheng Q; Lee J; Ma Z; Zhu Q; Wang Z
    J Cell Mol Med; 2015 Jun; 19(6):1223-33. PubMed ID: 25810125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation.
    Kezuka T; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1803-11. PubMed ID: 10845601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. siRNA-mediated silencing of PD-1 ligands enhances tumor-specific human T-cell effector functions.
    Iwamura K; Kato T; Miyahara Y; Naota H; Mineno J; Ikeda H; Shiku H
    Gene Ther; 2012 Oct; 19(10):959-66. PubMed ID: 22113316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.